The form collects basic information including your height, weight, medical history, current medications, and weight loss goals
The Croatian Phase I and II clinical trials for inflammatory bowel disease conducted in the 1990s by pharmaceutical company Pliva claimed safety with no significant toxicity, though complete peer-reviewed data never appeared in scientific literature beyond conference abstracts
If the patient achieves clinically meaningful weight reduction with obesity medications and if the clinician and patient feel that the medication is helping to avoid weight regain, then a weight reduction plateau should not be considered a point where medication should be discontinued, but rather the medication should be continued for weight reduction maintenance
A meta-analysis of randomized controlled trials of a traditional Chinese medicine prescription, modified RunChang-Tang, in treating functional constipation
Recent Developments in Medicare Advantage (Part C) Medicare Advantage the private-plan arm of Medicare continues to grow and evolve in 2025, with important implications for beneficiaries, insurers, and Medicares finances